- Home
- CERS vs PFL Comparison
CERS vs PFL Comparison
Compare CERS & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- PFL
- Stock Information
- Founded
- CERS 1991
- PFL 2003
- Country
- CERS United States
- PFL United States
- Employees
- CERS N/A
- PFL N/A
- Industry
- CERS EDP Services
- PFL Finance Companies
- Sector
- CERS Technology
- PFL Finance
- Exchange
- CERS Nasdaq
- PFL Nasdaq
- Market Cap
- CERS 347.3M
- PFL 333.6M
- IPO Year
- CERS 1997
- PFL N/A
- Fundamental
- Price
- CERS $1.40
- PFL $8.55
- Analyst Decision
- CERS Strong Buy
- PFL
- Analyst Count
- CERS 2
- PFL 0
- Target Price
- CERS $3.50
- PFL N/A
- AVG Volume (30 Days)
- CERS 1.5M
- PFL 113.7K
- Earning Date
- CERS 05-01-2025
- PFL 01-01-0001
- Dividend Yield
- CERS N/A
- PFL 11.53%
- EPS Growth
- CERS N/A
- PFL N/A
- EPS
- CERS N/A
- PFL N/A
- Revenue
- CERS $180,270,000.00
- PFL N/A
- Revenue This Year
- CERS $25.22
- PFL N/A
- Revenue Next Year
- CERS $10.08
- PFL N/A
- P/E Ratio
- CERS N/A
- PFL N/A
- Revenue Growth
- CERS 15.29
- PFL N/A
- 52 Week Low
- CERS $1.35
- PFL $6.98
- 52 Week High
- CERS $2.54
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- CERS 37.22
- PFL 53.94
- Support Level
- CERS $1.40
- PFL $8.51
- Resistance Level
- CERS $1.58
- PFL $8.59
- Average True Range (ATR)
- CERS 0.08
- PFL 0.04
- MACD
- CERS 0.00
- PFL 0.00
- Stochastic Oscillator
- CERS 20.83
- PFL 76.47
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.